Apatinib as an alternative therapy for advanced hepatocellular carcinoma

por Zhang, Xi-Hao, Cao, Man-Qing, Li, Xiu-Xiu, Zhang, Ti
Publicado 2020

IL-6 plays a crucial role in epithelial-mesenchymal transition and pro-metastasis induced by sorafenib in liver cancer

por Zhang, Ke-Wei, Wang, Dong, Cai, Hao, Cao, Man-Qing, Zhang, Yuan-Yuan, Zhuang, Peng-Yuan, Shen, Jun
Publicado 2021

PFKFB3 blockade inhibits hepatocellular carcinoma growth by impairing DNA repair through AKT

por Shi, Wen-Kai, Zhu, Xiao-Dong, Wang, Cheng-Hao, Zhang, Yuan-Yuan, Cai, Hao, Li, Xiao-Long, Cao, Man-Qing, Zhang, Shi-Zhe, Li, Kang-Shuai, Sun, Hui-Chuan
Publicado 2018

MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2

por Ma, De-Ning, Chai, Zong-Tao, Zhu, Xiao-Dong, Zhang, Ning, Zhan, Di-Hua, Ye, Bo-Gen, Wang, Cheng-Hao, Qin, Cheng-Dong, Zhao, Yi-Ming, Zhu, Wei-Ping, Cao, Man-Qing, Gao, Dong-Mei, Sun, Hui-Chuan, Tang, Zhao-You
Publicado 2016

NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma

por Li, Kang-Shuai, Zhu, Xiao-Dong, Liu, Hong-Da, Zhang, Shi-Zhe, Li, Xiao-Long, Xiao, Nan, Liu, Xue-Feng, Xu, Bin, Lei, Ming, Zhang, Yuan-Yuan, Shi, Wen-Kai, Cao, Man-Qing, Xu, Yun-Fei, Tang, Zhao-You, Sun, Hui-Chuan
Publicado 2020

miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

por Cao, Man-Qing, You, A-Bin, Zhu, Xiao-Dong, Zhang, Wei, Zhang, Yuan-Yuan, Zhang, Shi-Zhe, Zhang, Ke-wei, Cai, Hao, Shi, Wen-Kai, Li, Xiao-Long, Li, Kang-Shuai, Gao, Dong-Mei, Ma, De-Ning, Ye, Bo-Gen, Wang, Cheng-Hao, Qin, Cheng-Dong, Sun, Hui-Chuan, Zhang, Ti, Tang, Zhao-You
Publicado 2018

Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

por Cao, Man-Qing, You, A-Bin, Zhu, Xiao-Dong, Zhang, Wei, Zhang, Yuan-Yuan, Zhang, Shi-Zhe, Zhang, Kei-wei, Cai, Hao, Shi, Wen-Kai, Li, Xiao-Long, Li, Kang-Shuai, Gao, Dong-Mei, Ma, De-Ning, Ye, Bo-Gen, Wang, Cheng-Hao, Qin, Cheng-Dong, Sun, Hui-Chan, Zhang, Ti, Tang, Zhao-You
Publicado 2018